Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Yang Group

T cell immunity and immunosuppression in cancer

Group Leader

Jie Yang

Jie Yang

BVetMed, PhD

Group Leader - T cell immunity and immunosuppression in cancer

GROUP MEMBERS

Research Summary

T cells drive immune responses against cancer, but their function is constrained by immunosuppressive mechanisms that enable cancer progression and metastasis. Our research aims to uncover the molecular and cellular mechanisms underpinning immune regulation and cancer immunosuppression, with the goal of developing new approaches for cancer prevention and treatment of metastatic disease.

Our work combines cutting-edge mouse models, advanced cellular and molecular techniques, and translational approaches to understand how the immune system can be harnessed for cancer prevention and treatment. Fundamental discoveries in immune suppression mechanisms will pave the way for new preventive and therapeutic strategies that could transform outcomes for patients at risk of developing cancer or those with existing metastatic disease.

Our research vision focuses on:

  • T cell dysfunction and immune regulation: Identifying novel cellular and molecular inhibitory pathways that constrain cancer immunity and developing translatable therapeutic strategies to improve the efficacy of immunotherapy. 
  • Immune-based cancer prevention: Investigating how immune-modulating interventions, including biological therapies and readily available small molecule drugs like aspirin, could prevent cancer development and spread in high-risk populations.
  • Immune-metastasis interactions: Understanding how metastatic cancer cells evade immune surveillance and manipulate local immune environments, and identifying targetable pathways to enhance anti-metastatic immunity.

Joining the lab

We are looking for new group members with passion, talent, and grit! You will have the chance to work on grand challenges in the field of immune regulation and tumour immunity. You will be responsible for driving your research, identifying the most important questions, designing and performing experiments and publishing findings. We are happy to consider and support applications for talented postdoctoral researchers, PhD and Master's students. Please send me an email (jie.yang@oncology.ox.ac.uk) stating briefly why you are interested in joining the group and attaching a CV.

Latest publications